Structures by: Çaylak N.
Total: 18
4,4',6',6'-Tetrachloro-3-(4,6-dimethylpyridin-2-yl)-3,4-dihydrospiro[1,3,2- benzoxazaphosphinine-2,2'-(2λ^5^,4λ^5^,6λ^5^-cyclotriphosphazene)]
C14H14Cl4N5OP3
Acta Crystallographica Section E (2005) 61, 6 o1557-o1560
a=7.9310(5)Å b=11.9091(10)Å c=21.3948(15)Å
α=90.00° β=90.00° γ=90.00°
Diaquabis(4-chlorobenzoato-κ<i>O</i>)bis(nicotinamide-κ<i>N</i>)cobalt(II)
C26H24Cl2CoN4O8
Acta Crystallographica Section E (2007) 63, 5 m1344-m1346
a=7.5945(2)Å b=9.9333(2)Å c=10.0701(3)Å
α=78.900(10)° β=86.840(10)° γ=71.55(2)°
Diaquabis(4-bromobenzoato-κO)bis(nicotinamide-κN^1^)cobalt(II)
C26H24Br2CoN4O8
Acta Crystallographica Section E (2007) 63, 7 m1873-m1874
a=7.62020(10)Å b=9.9593(3)Å c=10.1125(2)Å
α=77.920(10)° β=85.650(10)° γ=71.65(2)°
2-(1H-Benzimidazol-1-yl)-1-phenylethanone oxime
C15H13N3O
Acta Crystallographica Section E (2007) 63, 8 o3463-o3464
a=9.32950(10)Å b=11.2863(2)Å c=12.5962(2)Å
α=90° β=90° γ=90°
2-(1H-Benzimidazol-1-yl)-1-(2-furyl)-3-phenylpropan-1-one
C20H16N2O2
Acta Crystallographica Section E (2007) 63, 8 o3638-o3638
a=16.3886(2)Å b=6.5976(2)Å c=16.7166(3)Å
α=90.00° β=114.677(9)° γ=90.00°
N,N-Bis[2-(2-furyl)-2-(hydroxyimino)ethyl]aniline
C18H17N3O4
Acta Crystallographica Section E (2007) 63, 9 o3827-o3828
a=11.2363(2)Å b=11.9889(3)Å c=12.8785(4)Å
α=90.00° β=109.886(10)° γ=90.00°
(3aR,10bR)-3a,4,10,10b-Tetrahydro-2H-furo[2,3-a]carbazol-5(3H)-one
C14H13NO2
Acta Crystallographica Section E (2007) 63, 9 o3913-o3914
a=9.5970(2)Å b=10.0316(3)Å c=12.4952(3)Å
α=98.498(15)° β=107.499(18)° γ=96.362(19)°
2-(1H-Benzimidazol-1-yl)-1-(furan-2-yl)ethanone O-2,4-dichlorobenzyloxime
C20H15Cl2N3O2
Acta Crystallographica Section E (2007) 63, 10 o4090-o4091
a=9.44070(10)Å b=5.3902(2)Å c=18.6522(3)Å
α=90.00° β=94.036(10)° γ=90.00°
Diaquabis(N,N-diethylnicotinamide-κN)bis(4-fluorobenzoato-κO)zinc(II)
C34H40F2N4O8Zn
Acta Crystallographica Section E (2007) 63, 10 m2561-m2562
a=7.4261(2)Å b=8.7188(3)Å c=15.0798(4)Å
α=98.44(2)° β=95.73(2)° γ=112.94(3)°
Diaquabis(4-fluorobenzoato-κO)bis(nicotinamide-κN^1^)cobalt(II)
C26H24CoF2N4O8
Acta Crystallographica Section E (2007) 63, 5 m1341-m1343
a=12.003(2)Å b=8.928(4)Å c=12.4219(18)Å
α=90.00° β=90.434(13)° γ=90.00°
N-(4-Methylbenzyl)-N-(6-methyl-2-pyridyl)benzenesulfonamide
C20H20N2O2S
Acta Crystallographica Section E (2007) 63, 5 o2261-o2262
a=8.83860(10)Å b=9.8790(2)Å c=10.5647(2)Å
α=89.589(5)° β=82.226(6)° γ=81.737(8)°
Diaquabis(4-bromobenzoato-κ^2^O,O)zinc(II)
C14H12Br2O6Zn
Acta Crystallographica Section E (2008) 64, 3 m458-m459
a=26.9067(3)Å b=5.0704(4)Å c=12.0371(5)Å
α=90.00° β=104.95(2)° γ=90.00°
Bis(4-fluorobenzoato-κ^2^O,O)bis(nicotinamide-κN^1^)zinc(II) monohydrate
C26H20F2N4O6Zn,H2O
Acta Crystallographica Section E (2008) 64, 3 m460-m461
a=8.2363(2)Å b=12.3711(2)Å c=14.8971(3)Å
α=113.178(14)° β=99.015(17)° γ=99.465(16)°
Diaquabis(4-chlorobenzoato-κO)bis(N,N-diethylnicotinamide-κN^1^)manganese(II)
C34H40Cl2MnN4O8
Acta Crystallographica Section E (2008) 64, 3 m505-m506
a=7.35520(10)Å b=8.6465(2)Å c=15.9847(3)Å
α=84.500(16)° β=78.616(17)° γ=68.154(17)°
C14H14Cl4N5O2P3
C14H14Cl4N5O2P3
Acta Crystallographica Section C (2004) 60, 7 o461-o463
a=9.045(2)Å b=11.647(3)Å c=12.225(2)Å
α=103.663(17)° β=107.458(19)° γ=109.78(2)°
1-Ethyl-<i>N</i>'-[(<i>E</i>)-4-hydroxybenzylidene]-7-methyl-4-oxo-1,4- dihydro-1,8-naphthyridine-3-carbohydrazide
C19H18N4O3
Acta Crystallographica Section E (2009) 65, 4 o860-o861
a=7.6437(2)Å b=13.3290(2)Å c=17.2212(4)Å
α=90.000000° β=98.1745(14)° γ=90.000000°
<i>N</i>-(4-Methoxy-2-nitrophenyl)-<i>N</i>-(methylsulfonyl)acetamide
C10H12N2O6S
Acta Crystallographica Section E (2009) 65, 5 o941
a=7.1512(2)Å b=15.4303(5)Å c=11.3217(3)Å
α=90.00° β=91.769(2)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-Benzylidene]-1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carbohydrazide
C19H18N4O2
Acta Crystallographica Section E (2009) 65, 12 o3152-o3153
a=7.16420(10)Å b=8.83830(10)Å c=14.4560(2)Å
α=82.624(6)° β=85.454(7)° γ=68.594(5)°